Product Images Exemestane
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Exemestane NDC 68382-383 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
3141272d 8016 4ad6 ba31 a8a62fde27ce 01
3141272d 8016 4ad6 ba31 a8a62fde27ce 02
This text represents statistical information regarding the survival rates of patients who were treated with either Exemestane or Tamoxifen, with the number of patients and events observed during the study. The proportion surviving is not clearly defined, but the Hazard Ratio (HR) is given with its corresponding confidence interval (95% Cl) and p-value (log-rank). The duration of disease-free survival is indicated in months on the X-axis, while the Y-axis shows the proportion of patients surviving at different time intervals.*
3141272d 8016 4ad6 ba31 a8a62fde27ce 03
Not available.*
3141272d 8016 4ad6 ba31 a8a62fde27ce 04
This is a description of a pharmaceutical product containing Exemestane, a drug used to treat breast cancer in postmenopausal women. The package contains 30 tablets, with each tablet coated and containing 25 mg of the drug. The usual dosage is available in the package insert. The product is child-resistant, and should be stored at a controlled temperature of 20°C to 25°C (68°F to 77°F). It should be kept in a tight container and out of reach of children. The product is manufactured by Cadla Healthcare Ltd and distributed by Zydus Pharmaceuticals (USA) Inc.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.